IL-1β secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin

被引:71
作者
Kelk, Peyman [1 ,3 ]
Claesson, Rolf [2 ]
Chen, Casey [4 ]
Sjostedt, Anders [3 ]
Johansson, Anders [1 ]
机构
[1] Umea Univ, Fac Med, Dept Odontol, Div Periodontol, SE-90185 Umea, Sweden
[2] Umea Univ, Fac Med, Dept Odontol, Div Oral Microbiol, SE-90185 Umea, Sweden
[3] Umea Univ, Fac Med, Dept Clin Microbiol, Div Clin Bacteriol, SE-90185 Umea, Sweden
[4] Univ So Calif, Sch Med, Div Primary Oral Hlth Care, Los Angeles, CA USA
关键词
A; actinomycetemcomitans; leukotoxin; IL-1; beta; macrophages;
D O I
10.1016/j.ijmm.2007.06.005
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Aggregatibacter (Actinobacillus) actinomycetemcomitans forms a leukotoxin that selectively lyses primate neutrophils, monocytes and triggers apoptosis in promyeloic cells and degranulation of human neutrophils. Recently, we showed that the leukotoxin causes activation of caspase-1 and abundant secretion of bio-active IL-1 beta from human macrophages. In this study, we show that high levels of IL-beta correlated with a high proportion of A. actinomycetemeomitans in clinical samples from a patient with aggressive periodontitis. To determine the relative contribution of leukotoxin to the overall bacteria-induced IL-1 beta secretion, macrophages were isolated from peripheral blood and exposed to different concentrations of live A. actinomycetemcomitans strains with either no, low or high production of leukotoxin. Cell lysis and levels of IL-1 beta, IL-6, TNF-alpha and caspase-1 were measured by ELISA and flow cytometry. Leukotoxin was the predominant cause of IL-1 beta secretion from macrophages, even in the A. actinomycetemcomitans strain with low leukotoxin production. Macrophages exposed to non-leukotoxic bacteria accumulated cytosolic pro-IL-1 beta, which was secreted by a secondary exposure to leukotoxic bacteria. In conclusion, the present study shows for the first time that A. actinomyeetemcomitans-induced IL-1 beta secretion from human macrophages in vitro is mainly caused by leukotoxin. (C) 2007 Elsevier GmbH. All rights reserved.
引用
收藏
页码:529 / 541
页数:13
相关论文
共 48 条
[1]
Assuma R, 1998, J IMMUNOL, V160, P403
[2]
INTERACTION OF INFLAMMATORY CELLS AND ORAL MICROORGANISMS .8. DETECTION OF LEUKOTOXIC ACTIVITY OF A PLAQUE-DERIVED GRAM-NEGATIVE MICROORGANISM [J].
BAEHNI, P ;
TSAI, CC ;
MCARTHUR, WP ;
HAMMOND, BF ;
TAICHMAN, NS .
INFECTION AND IMMUNITY, 1979, 24 (01) :233-243
[3]
Interleukin 1 signal transduction - Current concepts and relevance to periodontitis [J].
Boch, JA ;
Wara-aswapati, N ;
Auron, PE .
JOURNAL OF DENTAL RESEARCH, 2001, 80 (02) :400-407
[4]
REGULATION OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS LEUKOTOXIN EXPRESSION - ANALYSIS OF THE PROMOTER REGIONS OF LEUKOTOXIC AND MINIMALLY LEUKOTOXIC STRAINS [J].
BROGAN, JM ;
LALLY, ET ;
POULSEN, K ;
KILIAN, M ;
DEMUTH, DR .
INFECTION AND IMMUNITY, 1994, 62 (02) :501-508
[5]
Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure [J].
Bueno, LC ;
Mayer, MPA ;
DiRienzo, JM .
JOURNAL OF PERIODONTOLOGY, 1998, 69 (09) :998-1007
[6]
Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia [J].
Carlsson, Goran ;
Wahlin, Ylva-Britt ;
Johansson, Anders ;
Olsson, Anders ;
Eriksson, Torbjorn ;
Claesson, Rolf ;
Hanstrom, Lennart ;
Henter, Jan-Inge .
JOURNAL OF PERIODONTOLOGY, 2006, 77 (04) :744-751
[7]
Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists [J].
Delima, AJ ;
Karatzas, S ;
Amar, S ;
Graves, DT .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (04) :511-516
[8]
Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis [J].
Delima, AJ ;
Oates, T ;
Assuma, R ;
Schwartz, Z ;
Cochran, D ;
Amar, S ;
Graves, DT .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2001, 28 (03) :233-240
[9]
Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation [J].
Dinarello, CA .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :378-385
[10]
Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147